Literature DB >> 31853630

Feasibility and efficacy of repeat laparoscopic liver resection for recurrent hepatocellular carcinoma.

Takashi Onoe1,2, Megumi Yamaguchi3, Toshimitsu Irei3, Kohei Ishiyama3, Takeshi Sudo3, Naoto Hadano3, Masato Kojima3, Haruna Kubota3, Ryuta Ide3, Hirofumi Tazawa3, Wataru Shimizu3, Takahisa Suzuki3, Yosuke Shimizu3, Takao Hinoi3, Hirotaka Tashiro4,5.   

Abstract

BACKGROUND: Repeat hepatectomy is an acceptable treatment for recurrent hepatocellular carcinoma (HCC). However, repeat laparoscopic liver resection (LLR) has not been widely adopted due to its technical difficulty. This study aimed to assess the feasibility and efficacy of repeat LLR compared with repeat open liver resection (OLR) for recurrent HCC.
METHODS: We performed 42 repeat OLR and 30 repeat LLR for cases of recurrent HCC between January 2007 and March 2018. This study retrospectively compared the patients' clinicopathological characteristics and operative and short-term outcomes including surgical time, intraoperative blood loss, duration of hospital stay, and postoperative complications between the two groups.
RESULTS: There were no significant differences in patient characteristics between the two groups except in terms of Child-Pugh grade. The repeat LLR group had lower median intraoperative blood loss (100 mL vs. 435 mL; P = 0.001) and shorter median postoperative hospital stay (10 days vs. 14.5 days; P = 0.002). The other results including postoperative complications were comparable between the two groups. Further, comparison of two subpopulations of the repeat LLR group stratified by previous hepatectomy type (open or laparoscopic) or tumor location (segments 7 and 8 or other) revealed no significant differences in the postoperative clinical characteristics between them, although the morbidity rate tended to be higher in patients who underwent open hepatectomy for primary HCC than in patients who underwent laparoscopic hepatectomy.
CONCLUSIONS: Repeat LLR for recurrent HCC is feasible and useful with good short-term outcomes although an appropriate patient selection seems to be necessary.

Entities:  

Keywords:  Hepatocellular carcinoma; Laparoscopic liver resection; Repeat surgery

Mesh:

Year:  2019        PMID: 31853630     DOI: 10.1007/s00464-019-07246-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

1.  Laparoscopic versus open repeat liver resection for recurrent hepatocellular carcinoma in hepatectomy patients: inverse probability of treatment weighting.

Authors:  Eun Sung Jeong; Jong Man Kim; Manuel Lim; Jaehun Yang; Ji Eun Kwon; Gyu-Seong Choi; Jae-Won Joh
Journal:  Updates Surg       Date:  2022-02-26

2.  Laparoscopic vs open liver re-resection for cirrhotic patients with post-hepatectomy hepatocellular carcinoma recurrence: A comparative study.

Authors:  Kai-Chi Cheng; Kit-Man Ho
Journal:  World J Gastrointest Surg       Date:  2022-05-27

3.  Efficacy of laparoscopic repeat hepatectomy compared with open repeat hepatectomy: a single-center, propensity score matching study.

Authors:  Zefeng Shen; Jingwei Cai; Jiaqi Gao; Junhao Zheng; Liye Tao; Yuelong Liang; Junjie Xu; Xiao Liang
Journal:  World J Surg Oncol       Date:  2022-06-13       Impact factor: 3.253

4.  Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score-Matched Study and Meta-Analysis.

Authors:  Jia-Feng Chen; Xiu-Tao Fu; Zheng Gao; Ying-Hong Shi; Zheng Tang; Wei-Ren Liu; Xin Zhang; Qiang Gao; Guang-Yu Ding; Kang Song; Xiao-Ying Wang; Jian Zhou; Jia Fan; Zhen-Bin Ding
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

5.  Laparoscopic repeat hepatectomy versus conventional open repeat hepatectomy for recurrent hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Fulong Hao; Hancong Li; Nan Li; Jiaxin Li; Hong Wu
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

6.  Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases.

Authors:  Masaki Kaibori; Atsushi Hiraoka; Kosuke Matsui; Hideyuki Matsushima; Hisashi Kosaka; Hidekazu Yamamoto; Takashi Yamaguchi; Katsunori Yoshida; Mitsugu Sekimoto
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.